A generic alternative indicated for Eye Care. This clinical formulation assists in reducing elevated intraocular pressure associated with glaucoma or ocular hypertension.
Utilized to manage intraocular pressure by addressing fluid production to alleviate optic nerve strain and support long-term vision preservation in glaucoma patients.
Mechanism of Action
Brinzolamide blocks an enzyme called carbonic anhydrase in the eye. This enzyme is needed to produce aqueous humor, the fluid inside the eye. By reducing fluid production, it lowers the pressure within the eyeball.
Route of Administration
Ophthalmic
Onset Time
1–2 hours
Duration
8–12 hours
Contraindications
Severe kidney impairment, Hypersensitivity to sulfonamides, Hyperchloremic acidosis
Information for Azopt is sourced from established medical standards and updated frequently. It is provided for general reference and should be confirmed with a healthcare professional before use.